25 C
New York
Wednesday, September 22, 2021

Why Amyris Inc. (AMRS) stock plummeted on Tuesday, April 7, 2021?

Amyris Inc. (AMRS) stock lost 9.31% in the extended trading session after losing 7..46% in the morning session on Tuesday, April 7, 2021. AMRS shares have risen by 560.27% over the last 12 months, and they have moved down by -15.73% in the past week. Over the past three months, the stock has gained 110.35%, while over the past six months, it has added 430.50%.

3 Tiny Stocks Primed to Explode The world's greatest investor β€” Warren Buffett β€” has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


Proposed public offering of common stock

On April 7, 2021, Amyris, Inc. announced the initiation of a proposed underwritten public offering of shares of its common stock.

It’s a resale of the $150.0 million of shares stock on the behalf of its current stockholders, DSM International B.V. and Vivo Capital LLC. Amyris will not receive any proceeds and it is looking to offer 100.0 million shares of its common stock.

Additional $37.5 million of shares are expected to be available to underwriters in 30 days.

Partnership with Reese Witherspoon

On April 7, 2021, Amyris, Inc. signed a 5-year partnership with Reese Witherspoon as global brand ambassador for Biossance, one of the fastest-growing clean and sustainable skincare brands in the world.

The partnership will shape the future of clean beauty with the global leadership of Reese Witherspoon and with unparalleled expertise of Biossance in skincare efficacy, and clean beauty science.

Participation at Cowen’s 2nd Annual Consumer Platforms 

Amyris recently participated in a fireside chat at Cowen’s 2nd Annual Consumer Platforms for the Next Generation Summit which held on Tuesday, April 6th at 9:30 am ET.

Hosting the upcoming third webinar

On April 1, 2021, Amyris said that it will host the third webinar in its virtual investor mini-series themed “Delivering on the Promise of Synthetic Biology.”

The third webinar will be conducted via live webcast and teleconference on Thursday, April 22, 2021, at 1:00 pm ET (10:00 am PT) followed by a business update and end with a Q&A session.

Agreement with DSM Nutritional Products Ltd

On March 31, 2021, Amyris signed an agreement with DSM Nutritional Products Ltd to supply Amyris’s product portfolio of flavour and fragrance (F&F) ingredients exclusively.

The total agreement value is estimated at over $500 million and Amyris will continue to develop, scale and manufacture future molecules with its existing partners and DSM.

Record production of CBG

March 25, 2021, Amyris, Inc said that AMRS stock has set a record delivery f production of Cannabigerol (CBG) from fermentation for consumer skincare treatment formulations.


There is no news except the public offering of its common stock which could be the reason behind its sinking on Tuesday. The record shows that AMRS performed well and this negativity will be over soon.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.